Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can ancient qigong movements fortify pelvic health after childbirth?

NCT ID NCT07742202

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether a prenatal exercise program that combines Liuzijue qigong with traditional Kegel exercises, guided by a mobile app, can prevent postpartum urinary incontinence and pelvic organ prolapse. Pregnant women in their third trimester will be randomly assigned to one of three groups: the combined qigong-and-Kegel program, app-supervised Kegel exercises alone, or routine prenatal care with only verbal instructions. The study will compare the rates of urinary incontinence at six weeks postpartum, as well as adherence, pelvic floor function, and anxiety levels, to see if the integrated mind-body approach offers better protection than standard care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A supervised mobile app-guided program combining Liuzijue qigong with traditional levator ani (Kegel) exercises, based on the MoVo behavioral theory.
What this could lead to
If effective, this approach could offer a simple, app-based exercise routine to help pregnant women avoid postpartum urinary incontinence and pelvic organ prolapse.
What could go wrong
The trial is relatively small and the results may not apply to all women. Adherence to daily exercises could be challenging, and the added benefit over standard Kegel exercises is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 135 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 19 years * Singleton pregnancy with cephalic presentation; * No absolute contraindications to vaginal delivery; * No history of urinary incontinence, pelvic organ prolapse, or pelvic floor surgery before pregnancy; * Ability and willingness to comply with the full prenatal and postpartum follow-up schedule; * Signed written informed consent. Exclusion Criteria: * History of second- or third-trimester miscarriage, recurrent miscarriage, or spontaneous preterm birth; * Presence of pregnancy complications, such as severe preeclampsia, fetal distress, placenta previa, placental abruption, or symptoms of threatened preterm labour; * Contraindications to exercise, including cervical shortening, cervical insufficiency, or unexplained vaginal bleeding or fluid leakage; * Comorbid conditions, such as asthma, cardiovascular disease, hypertension, uncontrolled diabetes mellitus, or thyroid disease; * Metabolic bone disease or limited joint mobility; * Cognitive or psychiatric disorders that prevent the participant from completing diary records; * Concurrent participation in another pelvic floor intervention study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stress urinary incontinence are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.